Nursing care
Inhaled Corticosteroids: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 5 min read · Updated September 2026
Short answer
Inhaled corticosteroids such as fluticasone and budesonide reduce airway inflammation in asthma and COPD by acting locally in the lungs with minimal systemic absorption. The nursing priority is teaching the patient to rinse and spit after every dose, because the complication the exam tests is oral candidiasis, not systemic steroid effects.
What it does and why it is prescribed
Inhaled corticosteroids reduce airway inflammation by suppressing the local inflammatory cascade, decreasing mucosal oedema, mucus production, and bronchial hyperresponsiveness over time. They are the first-line controller therapy for persistent asthma and are used in combination inhalers for moderate to severe COPD, but they are maintenance medications, not rescue drugs, they do not relieve an acute bronchospasm in progress.
Common agents include fluticasone, budesonide, beclomethasone, and mometasone, delivered by metered-dose inhaler, dry powder inhaler, or nebuliser depending on the product and the patient's ability to coordinate a device. Because the drug acts locally at the site of inflammation rather than systemically, effective delivery technique matters as much as the prescription itself, a dose that lands on the back of the throat instead of the lower airway does very little for the patient's asthma.
Nursing considerations before giving it
Confirm the medication is a controller, not a rescue inhaler, and clarify with the patient or the chart that a short-acting beta agonist is available separately for acute symptoms, since confusing the two is a well-documented and dangerous patient error. Assess inhaler technique before assuming the prescribed dose is actually reaching the lungs; poor technique is one of the most common reasons a patient appears non-responsive to therapy.
If a spacer is prescribed with a metered-dose inhaler, confirm the patient is using it correctly, spacers improve deposition in the lower airway and reduce the amount of drug that settles in the oropharynx. Review the regimen for a combination product containing a long-acting beta agonist, since monotherapy with a long-acting beta agonist without an inhaled corticosteroid is unsafe in asthma. Ask about current oral or systemic steroid use, since combined exposure increases the risk of adrenal suppression with higher-dose or long-term inhaled therapy.
What to monitor
Monitor the oropharynx for white patches or plaques consistent with candidiasis at follow-up visits, and ask directly about hoarseness, throat irritation, or a persistent unpleasant taste, all of which point toward local steroid deposition rather than disease worsening. Track peak flow or spirometry trends and symptom frequency over weeks, since inhaled corticosteroids build their anti-inflammatory effect gradually and are not judged on a single dose.
In children on long-term therapy, monitor growth velocity at routine visits, since high-dose or prolonged use has been associated with a small, generally reversible reduction in growth rate. In patients on high-dose therapy or with additional systemic steroid exposure, watch for signs of adrenal suppression, unexplained fatigue, weakness, or poor response to physiologic stress, and monitor bone density in patients on long-term high-dose therapy.
Side effects versus adverse effects
The expected local side effects are oral candidiasis, hoarseness or dysphonia, and throat irritation, all a direct result of drug settling in the mouth and oropharynx rather than a sign of toxicity or overdose. These are common, predictable, and largely preventable with correct technique and rinsing, so they are managed rather than treated as a reason to stop the drug.
True adverse effects are far less common and reflect systemic absorption: adrenal suppression with high-dose or long-term use, reduced bone density, and a modest reduction in growth velocity in children. These systemic effects are dose- and duration-dependent and are the reason clinicians use the lowest effective dose, but for the vast majority of patients on standard doses, the local mucosal effects are what actually show up in practice, and they are the ones a nurse will teach around most often.
What to hold for and when to call
Hold the dose and notify the prescriber for signs of a significant oropharyngeal or systemic infection that needs to be assessed before adding a steroid, and for any acute bronchospasm or respiratory distress, since inhaled corticosteroids do not treat an acute attack and reliance on them in that moment delays appropriate rescue treatment. Report established oral candidiasis rather than treating it as routine, since it usually needs an antifungal and reinforced teaching, not silent tolerance.
Call for evaluation if a child on long-term therapy shows a clear drop-off in growth trajectory, or if a patient on high-dose therapy reports symptoms suggestive of adrenal suppression, particularly around illness, surgery, or other physiologic stress where the body's steroid demand rises. Report new or worsening hoarseness that does not improve with technique correction and rinsing, since it may need dose or device adjustment.
Patient teaching
Rinse the mouth with water and spit after every dose, without exception, because oral candidiasis is the complication most directly caused by inhaled corticosteroid use, and consistent rinsing is the single most effective way to prevent it. Teach patients this is not optional or only for high doses, it applies to every scheduled dose, every day, for as long as the medication is prescribed.
Confirm the patient can demonstrate correct inhaler technique, including breath-actuation timing for a metered-dose inhaler or the rapid, deep inhalation needed for a dry powder inhaler, and reinforce use of a spacer if one is prescribed. Teach the patient that this is a daily controller medication that must be taken consistently to build and maintain effect, it will not stop an attack already in progress, and a rescue inhaler must always be available separately. Advise reporting any white patches in the mouth, persistent hoarseness, or sore throat rather than assuming these are simply part of having the condition.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our respiratory practice questions are the closest set to what this page covers.
Common questions
Why do you rinse your mouth after using an inhaled corticosteroid?
Rinsing and spitting removes drug residue left in the mouth and throat, which otherwise creates a local environment where Candida can overgrow. Oral candidiasis is the specific complication this teaching prevents, and it should be done after every single dose, not just high doses.
Can an inhaled corticosteroid be used for an acute asthma attack?
No. Inhaled corticosteroids are controller medications that reduce airway inflammation over time; they do not relieve acute bronchospasm. A short-acting beta agonist rescue inhaler is used for acute symptoms, and the two should never be confused.
What is the difference between a side effect and an adverse effect with inhaled corticosteroids?
The expected side effects are local: oral candidiasis, hoarseness, and throat irritation from drug deposition in the mouth. Adverse effects reflect systemic absorption, such as adrenal suppression, reduced bone density, or slowed growth in children, and are dose- and duration-dependent.
Do inhaled corticosteroids affect growth in children?
Long-term or high-dose use has been associated with a small, generally reversible reduction in growth velocity, so growth is monitored at routine visits in children on long-term therapy. This is weighed against the risk of poorly controlled asthma, which itself can affect growth and activity.
What should a patient do if white patches appear in the mouth after starting an inhaled corticosteroid?
Report it rather than treating it as expected. White patches suggest oral candidiasis, which typically needs an antifungal treatment and reinforced teaching on rinsing technique and, where applicable, spacer use.